Revenue
0 USD
2012 Q3 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Market value is not computed: no recent price is available.
51 filing records in this dataset, filed from 2008-04-07 to 2016-06-01. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
This issuer has insider filings in the store, but no transaction in this window or code group.
100000 USD
57640958 shares
-94.30% · -954 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
-25.9 million USD
2015-04-01 – 2016-03-31
-10.7 million USD
2015-04-01 – 2016-03-31
48 thousand USD
2014-10-01 – 2015-09-30
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2016-06-01.
Financial data available through: 2015-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 27.28 million
–
Current period
−USD 25.21 million
–
-25214000 − -27277000 = 2063000 USD
-27277000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source-25214000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 11.33 million
–
Current period
−USD 16.01 million
–
-16014000 − -11331000 = -4683000 USD
-11331000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source-16014000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 181,000
–
Current period
USD 10,000
–
10000 − 181000 = -171000 USD
181000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source10000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2011 2011-01-01 – 2011-12-31 | 223588 | 4663691 Derived | -4440103 | 0 Derived | -4440103 | Unavailable | Source
|
| 2012 2012-01-01 – 2012-12-31 | 0 | 4090342 Derived | -4090342 | 1045276 Derived | -5135618 | -1154126 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2011 | Revenue | 223588 |
|
| 2012 | Revenue | 0 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2011 | Year over year | No prior comparable period |
|
| 2012 | Year over year | -100% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2011 | Operating margin | -1,985.8% |
|
| 2012 | Operating margin | Not reported |
|
| 2011 | Net margin | -1,985.8% |
|
| 2012 | Net margin | Not reported |
|
| 2011 | Free cash flow margin | Not reported |
|
| 2012 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2011 | Operating cash flow | -2815514 |
|
| 2012 | Operating cash flow | -1154126 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2011 | Free cash flow | Unavailable |
|
| 2012 | Free cash flow | -1154126 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2011 | Liabilities / assets | 1,044.3% |
|
| 2012 | Liabilities / assets | 391.6% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2011 | Current assets / current liabilities | 0.09× |
|
| 2012 | Current assets / current liabilities | 0.14× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2008 2008-01-14 – 2008-12-31 | −USD 406,706 Exact valueExact value: -406706 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2009 2009-01-01 – 2009-12-31 | −USD 306,190 Exact valueExact value: -306190 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2010 2010-01-01 – 2010-12-31 | −USD 1.21 million Exact valueExact value: -1207561 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 538,549 Exact valueExact value: -538549 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable The mapped spending value is negative, so its direction is unclear. | Unavailable Capital expenditure has a negative mapped value; spending direction is unclear. |
| 2011 2011-01-01 – 2011-12-31 | −USD 4.44 million Exact valueExact value: -4440103 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.82 million Exact valueExact value: -2815514 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable The mapped spending value is negative, so its direction is unclear. | Unavailable Capital expenditure has a negative mapped value; spending direction is unclear. |
| 2012 2012-01-01 – 2012-12-31 | −USD 5.14 million Exact valueExact value: -5135618 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.15 million Exact valueExact value: -1154126 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.15 million Calculation and evidence-1154126 − 0 USD Exact free cash flow: -1154126 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2013 2013-01-01 – 2013-12-31 | −USD 15.13 million Exact valueExact value: -15132000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.47 million Exact valueExact value: -3473000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.47 million Calculation and evidence-3473000 − 0 USD Exact free cash flow: -3473000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2014 2014-01-01 – 2014-12-31 | −USD 27.28 million Exact valueExact value: -27277000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 11.33 million Exact valueExact value: -11331000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 181,000 Exact valueExact value: 181000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 11.51 million Calculation and evidence-11331000 − 181000 USD Exact free cash flow: -11512000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2015 2015-01-01 – 2015-12-31 | −USD 25.21 million Exact valueExact value: -25214000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 16.01 million Exact valueExact value: -16014000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 10,000 Exact valueExact value: 10000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 16.02 million Calculation and evidence-16014000 − 10000 USD Exact free cash flow: -16024000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
51 filings · 1,310 latest values · 1,310 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001424812, 1424812, AMBS, AMBSE, edgar:1424812
Also known as AMARANTUS BIOSCIENCE, INC., Amarantus BioSciences, Inc., Amarantus Bioscience Holdings, Inc., Amarantus Biosciences, Inc., Jumpkicks, Inc.